You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賽諾醫療(688108.SH):未來公司的產品肯定是會佈局很多產品線
格隆匯 06-12 18:31

格隆匯6月12日丨有投資者向賽諾醫療(688108.SH)提問:目前冠脈市場已經卷的不行,如果我們投入很大的精力去做海外的銷售,是不是性價比不高,反而神經領域的回報是不是會更高?

賽諾醫療回覆:支架市場在中國實際上是從一個很大的市場被壓縮到一個很小的市場,但是未來的市場空間還是很大的,未來美國的市場會到 100 多萬例,按照體量和經濟發展來算,中國的市場也會有 300 萬例。

未來公司的產品肯定是會佈局很多產品線,比如普通冠脈支架和普通球囊產品是用來鋪面的,神經類的幾款重磅產品是集中掙錢的,同時在冠脈類還會開發一些特種支架和球囊,像是我們的全降解鎂合金支架和棘突球囊。這樣整個冠脈產品從開通到治療再到周圍的配件會會形成系列產品。除此之外,由於公司有最好的技術平台,包括塗層技術、藥物釋放技術等,產品還可以擴展到瓣膜瓣架等方面。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account